In vitro Antibacterial Activity of Ethanolic Tanao Si Kan Dang RD1 (Cannabis sativa L.) Extracts Against Human Antibiotic-Resistant Bacteria.

Abstract

<b>Background and Objective:</b> A new strain of cannabis, <i>Cannabis sativa</i> L. Tanao Si Kan Dang RD1, has been approved and registered by the Rajamangala University of Technology Isan, Thailand. The <i>C. sativa</i> is acknowledged for its medicinal properties which demonstrated various therapeutic properties, such as anti-cancer and antibacterial activities. This study aimed to investigate the antibacterial activity of ethanolic extracts from the stems and leaves of the Tanao Si Kan Dang RD1 strain against seven antibiotic-resistant bacteria. <b>Materials and Methods:</b> The primary antibacterial activity of ethanolic Tanao Si Kan Dang RD1 extracts were determined using the disc diffusion method, while the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined using the broth microdilution method. <b>Results:</b> The largest inhibition zone, measuring 12 mm, was observed in leaf extracts against <i>Pseudomonas aeruginosa</i> 101. The lowest MIC, at 0.78 mg/mL, was obtained from stem extracts against <i>Stenotrophomonas maltophilia</i>. The lowest MBCs, at 12.5 mg/mL, were observed in leaf extracts against <i>Enterococcus faecalis</i>, <i>Acinetobacter baumannii</i>, multidrug-resistant <i>Klebsiella</i> <i>pneumoniae</i>, <i>Stenotrophomonas maltophilia</i> and <i>Pseudomonas aeruginosa</i> 101 and stem extracts against <i>Acinetobacter baumannii</i>, multidrug-resistant <i>Klebsiella pneumoniae</i>, <i>Stenotrophomonas maltophilia</i> and <i>Pseudomonas aeruginosa</i> 101. <b>Conclusion:</b> This study presents a novel finding regarding the antibacterial activity of ethanolic extracts from the leaves and stems of Tanao Si Kan Dang RD1 against antibiotic-resistant bacteria. The potential application of these cannabis plant extracts in the development of antibiotics capable of combating antibiotic-resistant pathogenic bacteria represents a promising strategy to address a significant global health concern.